Results 1 to 10 of about 188,070 (188)

Prognostic value of cross‐lineage expression of the myeloid‐associated antigens CD13 and CD33 in adult B‐lymphoblastic leukemia: A large real‐world study of 1005 patients

Cancer Medicine, 2023
Background Cross‐lineage expression of the myeloid‐associated antigens CD13/CD33 is common in adult B‐lymphoblastic leukemia (B‐ALL) patients, yet its prognostic value is still controversial.
Hongyan Liao, Hongli Lai, Jiao Chen, Xiao Shuai, Xin Zhang, Ying Yang, Mengyuan Lyu, Qin Zheng   +7 more
doaj   +5 more sources

CD13 is a bona-fide marker of bovine pre-adipocytes with potential in cultivated fat applications [PDF]

npj Science of Food
Despite its significant potential, cultivated fat manufacture remains a relatively inefficient process, as it primarily uses source preparations of animal-derived mesenchymal stem/stromal cells (MSC) that are poorly defined and highly heterogenous in ...
Seungmee Lee, Thomas Thrower, Susanna E. Riley, Cristina L. Esteves, F. Xavier Donadeu   +4 more
doaj   +3 more sources

Multiple Gastric Involvement by Myeloid Antigen CD13-Positive Non-Secretory Plasma Cell Leukaemia [PDF]

British Journal of Haematology, 1996
Gastrointestinal tract involvement is a rare complication of plasma cell neoplasia. We present a case of non‐secretory type primary plasma cell leukaemia (PCL) with multiple gastric involvement. Dual surface antigen analysis of bone marrow cells revealed that atypical plasma cells coexpressed CD38 and myeloid antigen CD13.
Shinji Hirai, Masahiro Kikuchi, Yuji Oka
exaly   +3 more sources

CD13 (Aminopeptidase N) Can Associate With Tumor-Associated Antigen L6 and Enhance the Motility of Human Lung Cancer Cells [PDF]

International Journal of Cancer, 2005
AbstractCancer metastasis is a multiple‐step process that involves the regulated interaction of diverse cellular proteins. We recently reported that the expression of tumor‐associated antigen L6 (TAL6) promoted the invasiveness of lung cancer cells and was inversely correlated with disease‐free survival of squamous lung carcinoma patients.
Pan-chyr Yang, Yeou-Guang Tsay, Cheng-Wen Wu   +2 more
exaly   +3 more sources

Characterization of CD13 and CD33 Surface Antigen–Negative Acute Myeloid Leukemia [PDF]

American Journal of Clinical Pathology, 2000
From a cohort of 220 adults with newly diagnosed acute myeloid leukemia (AML), 8 (3.6%) exhibited a rare variant of aberrant membrane phenotype. It was characterized with typical myeloid morphologic and cytochemical patterns and absence of myeloid associated antigens (CD13, CD33, CD14, glycophorin A, CD61).
N, Kraguljac, D, Marisavljevic, G, Jankovic, N, Radosevic, M, Pantic, M, Donfrid, N, Miletic, D, Boskovic, M, Colovic   +8 more
openaire   +2 more sources

Immunophenotypic Aberrancies in Acute Leukemia: A Tertiary Care Centre Experience

Oman Medical Journal, 2021
Objectives: Acute leukemias (AL) are a heterogeneous group of hematological malignancies with the presence of 20% or more blasts in the peripheral blood or bone marrow.
Monika Gupta, Lovekesh Monga, Dimple Mehrotra, Sonia Chhabra, Shivani Singhal, Rajeev Sen   +5 more
doaj   +1 more source

Myeloid Antigen, CD13, CD14, and/or CD33 Expression Is Restricted to Certain Lymphoid Neoplasms [PDF]

American Journal of Clinical Pathology, 1996
The authors examined the expression of myeloid antigens (MyAg): CD11b, CD13, CD14, CD15, and CD33 in 249 adults with lymphoid neoplasms using flow cytometric analysis. In this study, acute leukemia that was myeloperoxidase negative by light microscopy and had at least one lymphoid antigen was defined as acute lymphoblastic leukemia (ALL).
K, Nakase, K, Kita, H, Shiku, I, Tanaka, K, Nasu, H, Dohy, T, Kyo, H, Tsutani, N, Kamada   +8 more
openaire   +2 more sources

Spectrum of immunophenotypic aberrancies in acute leukemia along with their correlation with adverse hematological parameters

Indian Journal of Health Sciences and Biomedical Research KLEU, 2022
BACKGROUND: The identification of aberrant phenotypes in acute leukemia is crucial for treatment monitoring and minimal residual disease analysis.
Sana Ahuja, Avneesh Malviya
doaj   +1 more source

The Expression of Myeloid Antigens CD13 and/or CD33 Is a Marker of ALK+ Anaplastic Large Cell Lymphomas [PDF]

American Journal of Clinical Pathology, 2008
We retrospectively studied the immunophenotype by flow cytometry of 20 anaplastic large cell lymphomas (ALCLs) (9 anaplastic lymphoma kinase [ALK]+ and 11 ALK-) with a particular emphasis on the aberrant expression of the myeloid associated antigens CD13 and/or CD33. All ALCLs expressed CD45, HLA-DR, and CD30. Most (8/9) ALK+ ALCLs expressed at least 1
Ian M, Bovio, Robert W, Allan
openaire   +2 more sources

Targeted delivery of oral vaccine antigens to aminopeptidase N protects pigs against pathogenic E. coli challenge infection

Frontiers in Immunology, 2023
Oral subunit vaccines are an interesting alternative strategy to traditional live-attenuated or inactivated vaccines for conferring protection against gut pathogens.
Hans Van der Weken, Hamid Reza Jahantigh, Hamid Reza Jahantigh, Eric Cox, Bert Devriendt   +4 more
doaj   +1 more source